Waters (NYSE:WAT) will announce its earnings results before the market opens on Tuesday, January 23rd. Analysts expect the company to announce earnings of $2.43 per share for the quarter.
Waters (NYSE:WAT) last issued its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.03. Waters had a return on equity of 23.61% and a net margin of 24.34%. The company had revenue of $565.58 million for the quarter, compared to analyst estimates of $555.25 million. During the same period in the prior year, the firm earned $1.57 earnings per share. Waters’s revenue for the quarter was up 7.4% on a year-over-year basis. On average, analysts expect Waters to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.
Waters (NYSE WAT) opened at $210.72 on Monday. The company has a current ratio of 6.16, a quick ratio of 5.71 and a debt-to-equity ratio of 0.66. Waters has a 12-month low of $137.72 and a 12-month high of $211.65. The firm has a market capitalization of $16,759.19, a P/E ratio of 31.08, a PEG ratio of 2.82 and a beta of 0.82.
In other news, Director William J. Miller sold 3,500 shares of the firm’s stock in a transaction on Tuesday, December 5th. The stock was sold at an average price of $194.94, for a total transaction of $682,290.00. Following the completion of the sale, the director now directly owns 25,849 shares of the company’s stock, valued at approximately $5,039,004.06. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Elizabeth B. Rae sold 12,000 shares of the firm’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $197.95, for a total value of $2,375,400.00. Following the sale, the senior vice president now directly owns 18,129 shares of the company’s stock, valued at $3,588,635.55. The disclosure for this sale can be found here. Insiders sold a total of 93,159 shares of company stock valued at $18,412,172 over the last three months. 5.07% of the stock is currently owned by insiders.
A number of equities analysts have recently weighed in on WAT shares. Deutsche Bank upped their target price on Waters from $199.00 to $200.00 and gave the stock a “hold” rating in a research report on Wednesday, October 25th. Bank of America increased their price target on Waters from $192.00 to $202.00 and gave the company a “neutral” rating in a research report on Friday, November 10th. Barclays increased their price target on Waters from $188.00 to $193.00 and gave the company an “equal weight” rating in a research report on Wednesday, October 25th. Zacks Investment Research raised Waters from a “hold” rating to a “buy” rating and set a $211.00 price target for the company in a research report on Monday, October 23rd. Finally, Cowen reissued a “hold” rating and issued a $190.00 price target on shares of Waters in a research report on Friday, November 3rd. Eleven analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $197.33.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.